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Abstract
Background The UK hip fracture best practice tariff
(BPT) aims to deliver hip fracture surgery within 36 h of
admission. Ensuring that delays are reserved for conditions
which compromise survival, but are responsive to medical
optimisation, would help to achieve this target. We aimed
to identify medical risk factors of surgical delay, and assess
their impact on mortality.
Materials and methods Prospectively collected patient
data was obtained from the National Hip Fracture Database
(NHFD). Medical determinants of surgical delay were
identified and analysed using a multivariate regression
analysis. The mortality risk associated with each factor
contributing to surgical delay was then calculated.
Results A total 1361 patients underwent hip fracture
surgery, of which 537 patients (39.5 %) received surgery
within 36 h of admission. Following multivariate analyses,
only hyponatraemia was deduced to be a significant risk
factor for delay RR = 1.24 (95 % CI 1.06–1.44). However,
following a validated propensity score matching process,
a Pearson chi-square test failed to demonstrate a statistical
difference in mortality incidence between the hypo-
and normonatraemic patients [v2(1, N = 512) = 0.10,
p = 0.757].
Conclusions Hip fracture surgery should not be delayed
in the presence of non-severe and isolated hyponatraemia.
Instead, surgical delay may only be warranted in the
presence of medical conditions which contribute to mor-
tality and are optimisable.
Level of evidence III
Keywords Hip fractures  Time to treatment  36 h
Introduction
A fracture of the hip is the commonest cause of injury-
related death in the UK [1]. Prompt surgery has been
associated with higher rates of independent living and
lower 30-day and 1-year mortality rates [2–5]. Earlier
surgery has also been shown to improve patient outcomes
by reducing pain scores, and lowering of the risk of decu-
bitus ulcer formation and length of inpatient stay [2, 6, 7].
The inception of best practice tariffs (BPTs), which
aimed to improve these patient outcomes, stemmed from
the ‘Equity and Excellence: liberating the NHS’ govern-
ment white paper [8]. BPTs are incentivised targets, which
financially compensate organisations for delivering high
quality care. In the context of hip fracture management, the
BPT consists of an initial base tariff, with additional pay-
ments if further criteria of best practice have been met. One
of these criteria is delivering hip fracture surgery within
36 h of presentation to a health care institution. This
government target is also in accordance with clinical
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guidelines set by the British Orthopaedic Association
(BOA) and National Institute of Clinical Excellence
(NICE), which state that hip fracture surgery should be
performed on the day of, or the day after admission and
within normal working hours [9, 10]. However, the
National Hip Fracture Database (NHFD) has reported that
this specific BPT target was met in only 71.4 % of hip
fracture patients, equating to £15.9 million in ‘lost’ mon-
etary incentives [1].
Clearly, resources must be made available to allow such
a level of service provision and to qualify for the maximum
financial reward the BPT has to offer. Optimal clinical
decision-making could therefore augment and streamline
management in order to facilitate early surgery. As survival
is perhaps the most desirable outcome following a fracture
of the neck of femur (FNOF), and delay to surgery in itself
carries an increased risk to mortality, then it certainly
follows that delays for medical optimisation would only be
justified for conditions which also carry a mortality risk [3–
7]. Therefore, identifying medical risk factors for surgical
delay and their associated mortality risk would assist
organisations to rationalise clinical decision-making, and
thus enhance compliance with the BPT target.
The primary aim of this study was therefore to identify
medical conditions associated with patients failing to
achieve the 36-h cut-off for surgery following a hip frac-
ture. We subsequently evaluated whether these factors
were justifiable in risking surgical delay by gauging whe-
ther they were also associated with an increased risk to
mortality.
Materials and methods
We obtained prospectively collected hip fracture patient
information from the UK NHFD from before April 2010
and prior to the inception of the 36-h BPT guideline. Data
was subsequently cross-referenced with our institution’s
patient records. The use of data after the introduction of the
BPT guidelines may have risked missing patients with
legitimate causes of delay, who may have had their surgery
expedited to meet the 36-h target. Hence analysis of delays
was performed on data pre-dating the BPT introduction,
allowing all medical causes of delays to be identified and
an assessment of their risk to mortality to be performed.
We collected patient-level information including
demographic data, American Society of Anesthesiologists
(ASA) grade at the time of surgery, fracture type, source of
admission and walking ability [11]. All patient co-mor-
bidity data was identified using the International Classifi-
cation of Disease 10th revision (ICD-10) codes, and these
were used to calculate the Charlson co-morbidity index for
each patient as a separate variable [12]. Biochemical
parameters collected included admission haemoglobin
levels (Hb), white cell count (WCC), coagulation profile,
urea and electrolyte levels. Time to surgery from presen-
tation was also collected.
The primary outcome of interest was a delay to surgery
over 36 h from initial hospital presentation. The secondary
outcome examined was the occurrence and causes of
mortality within 30 days of admission. Primary and sec-
ondary causes of death were noted from death certificates
and hospital death records. A total of 1674 patients were
initially identified, but following exclusions of incomplete
data sets and incorrect or duplicate entries, a total of 1361
patients were included in the study.
Statistical analysis was undertaken in a two-stage pro-
cess. We initially categorised patients into two groups:
group1 = time to surgery\36 h; group 2 = time to sur-
gery[36 h). All variables collected were then compared
between these two groups on initial univariate analysis
using the chi-square or Fisher’s exact test for categorical
data and the independent t/Mann–Whitney test for contin-
uous variables. A subsequent backward stepwise Cox
regression model was undertaken to identify the most
significant determinants of surgical delay beyond 36 h. Our
criteria for inclusion of variables into the model included a
p value\0.15 on univariate analysis, in accordance with
published statistical methods [13]. Results were displayed
as relative risks rather than odds ratios, in order to aid
clinical interpretation [14].
The decision to delay hip fracture surgery on medical
grounds is undertaken to avoid significant complications
which may result from precipitous surgery. Death is per-
haps the most important complication to avoid. Therefore,
it is logical to validate variables that risk a delay to surgery
beyond 36 h in terms of their impact on mortality. We
undertook a second-stage analysis to assess mortality
likelihood at 30 days following surgery for each individual
variable which had been found to delay surgery. To limit
potential for selection bias, when assessing one variable’s
association with mortality we had to control for all other
variables. We therefore derived a single scalar propensity
score from the regression of all remaining covariates in
Tables 1 and 2. Between-group propensity score matching
was performed using a ‘‘nearest neighbour’’ matching
strategy [15]. An assessment of the matching process
consisted of an evaluation of between-group standardised
mean differences and variance ratios according to pub-
lished standards [16]. Between-group mortality analysis
used a chi-square test for each variable influencing surgical
delay only after the matching process had been verified as
being successful in balancing covariates between the two
groups.
208 J Orthopaed Traumatol (2016) 17:207–213
123
Results
A total 1361 patients underwent hip fracture surgery, of
which 537 patients (39.5 %) received surgery within 36 h
of admission. The overall median time to surgery from
presentation was 23 h (3–36) in group 1 and 72 h (36–774)
in group 2. The demographics were similar between
patients who did (group 1) and those who did not (group 2)
receive timely surgery (Table 1). There was no difference
between the two groups with respect to age, gender,
walking ability, fracture pattern and ASA grade. However,
with regards to admission source, there was a higher pro-
portion of patients presenting from a community care
institution in group 1, whilst a higher proportion of patients
were from their own home in group 2 (p = 0.013).
The distribution of the different co-morbidities between
the two groups are summarised in Table 2. There was a
higher proportion of patients with cardiac co-morbidities in
group 1, while a higher proportion of patients in group 2
presented with hyponatraemia (sodium \135 mmol/l)
(p = 0.00). There was no difference between the two
groups with respect to a number of factors, including pre-
existing anticoagulation therapy (p = 0.303). Furthermore,
the calculated Charlson’s co-morbidity index was also
similar between the two groups (p = 0.835). There was no
statistical difference in haematological and serum bio-
chemical parameters between the two groups (Table 2).
Following univariate analysis, seven variables, includ-
ing admission source, history of dementia, ischaemic heart
disease, MI, cerebrovascular accidents (CVA), urinary tract
infections and hyponatraemia met criteria for inclusion into
the Cox regression model. The model thereafter inferred
only hyponatraemia to be a significant risk factor for delay
to surgery beyond 36 h with a covariate adjusted relative
risk (RR) 1.24 (95 % CI 1.06–1.44, p = 0.006).
The overall 30-day mortality in our cohort of hip frac-
ture patients was 9.0 %. The commonest cause of death
was from pneumonia (37 %). Following propensity score
analysis, 256 patients with hyponatraemia were matched to
256 patients with normal sodium levels. The absolute
acceptable propensity score caliper width was 0.01. A near
perfect standardised mean difference of 0.0003 and a
variance ratio of 1 (0.01:0.01) confirmed between-group
homogeneity to be well within acceptable limits [16]. Thus,
Table 1 Comparison of
demographic data between
subjects who did and those who
did not have surgery within 36 h
of admission
Variables Time to surgery\36 h Time to surgery[36 h p value
Number 537 (39.5 %) 824 (60.5 %) 0.01
Age in years 84 (24–103) 83 (31–104) 0.279
Gender – – 0.674
Male 143 (26.6 %) 228 (27.6 %) –
Female 394 (73.4 %) 596 (72.4 %) –
Fracture type – – 0.228
Intracapsular undisplaced 197 (36.7 %) 263 (31.9 %) –
Intracapsular displaced 156 (29.1 %) 277 (33.6 %) –
Intertrochanteric 140 (26.1 %) 217 (26.3 %) –
Subtrochanteric 44 (8.2 %) 67 (8.1 %) –
Admission source – – 0.031a
Own home 390 (72.6 %) 650 (78.8 %) –
Residential/nursing home 118 (22.0 %) 128 (15.5 %) –
Already inpatient 11 (2.0 %) 24 (2.9 %) –
Other hospital 2 (0.4 %) 2 (0.2 %) –
Unknown/other 16 (3.0 %) 20 (2.4 %) –
Pre-injury walking ability – – 0.664
Independent 285 (55.1 %) 439 (53.2 %) –
1 stick 122 (22.7 %) 203 (24.6 %) –
2 sticks or frame 99 (18.4 %) 148 (17.9 %) –
Wheelchair/scooter 12 (2.2 %) 13 (1.6 %) –
Unknown 19(3.5 %) 21(%) –
Results are displayed as median (range) for continuous data, and as n (%) of population for discrete data
Continuous data were analysed using an independent t-test, categorical data using chi-square/Fisher’s test
and ordinal data using the Mann–Whitney–Wilcoxon test
a Included in the multivariate analysis
J Orthopaed Traumatol (2016) 17:207–213 209
123
Table 2 Comparison of clinical
data between subjects who did
and those who did not have
surgery within 36 h of hospital
admission
Variable Time to surgery\36 h Time to surgery[36 h p value
Co-morbidities
Dementia 46 (8.6 %) 52 (6.3 %) 0.116a
Hypertension 18 (3.4 %) 25 (3.0 %) 0.743
Diabetes mellitus 50 (9.3 %) 89 (10.8 %) 0.375
Ischaemic heart dis. 161 (30 %) 195 (23.6 %) 0.010a
COPD/asthma 75 (14 %) 126 (15.3 %) 0.501
Neurological dis. 12 (2.2 %) 17 (2.1 %) 0.830
Stroke 25 (4.7 %) 24 (2.9 %) 0.092a
Thyroid dis. 33 (6.1 %) 43 (5.2 %) 0.467
Malignancy 50 (9.3 %) 79 (9.6 %) 0.865
Alcoholism 18 (3.4 %) 25 (3.0 %) 0.743
Chest infection 66 (12.3 %) 97 (11.8 %) 0.773
Urinary tract infection 99 (18.4 %) 123 (14.9 %) 0.087a
Myocardial infarction 22 (4.1 %) 17 (2.1 %) 0.028a
Cardiac failure 16 (3.0 %) 23 (2.8 %) 0.839
Peripheral vascular dis. 6 (1.1 %) 13 (1.6 %) 0.638b
Peptic ulcer dis. 4 (0.7 %) 5 (0.6 %) 0.745b
Liver disease 4 (0.7 %) 3 (0.4 %) 0.444b
Connective tissue dis. 0 (0 %) 1 (0.1 %) 1.0b
Leukaemia 1 (0.2 %) 3 (0.4 %) 1.0b
Anaemia 64 (11.9 %) 105 (12.7 %) 0.652
Chronic renal failure 41 (7.6 %) 79 (9.6 %) 0.214
Hyponatraemia 96 (17.9 %) 233 (28.2 %) 0.000a
Anticoagulation therapy 7 (1.3 %) 18 (2.2 %) 0.303b
Blood results on admission
HB 12.1 (6–17) 12.0 (7–19) 0.563
Platelet count 264 (43–843) 264 (43–938) 0.313
White cell count 10.3 (4–78) 10.3 (1–67) 0.754
Urea 7.4 (1–34) 7.2 (1–36) 0.950
Creatinine 93 (50–817) 92 (42–512) 0.949
Potassium (K?) 4.4 (2–7) 4.3 (3–7) 0.805
INR 1 (0.8–5.6) 1 (0.8–6.3) 0.540
APTT 29 (20–190) 29 (19–195) 0.450
ASA 0.685
1 52 (9.7 %) 68 (8.3 %)
2 135 (25.1 %) 226 (27.4 %)
3 282 (52.5 %) 420 (51.0 %)
4 68 (12.7 %) 109 (13.2 %)
5 0 (0 %) 1 (0.1 %)
Charlson score (median, range) 4 (0–8) 4 (0–9) 0.835
Results are displayed as median (range) for continuous data, and as n (%) of population for discrete data
Continuous data were analysed using an independent t-test, categorical data using chi-square/Fisher’s test
and ordinal data using the Mann–Whitney–Wilcoxon test
Displayed blood results are serum values in mmol/l
INR international normalised ratio, APTT activated partial thromboplastin time
a Included in multivariate analysis
b Fisher’s exact test used
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the matching process controlled for all collected variables,
including time to surgery. The 30-day mortality rates for
hyponatraemic patients was 10 % (24/256) and 9 % (22/
256) for normonatraemic patients. This was not statistically
significant (p = 0.757).
Discussion
Our study has shown that 60.5 % of patients had surgery
delayed beyond 36 h. Furthermore, hyponatraemia was
identified as a pre-operative risk factor for this. Interest-
ingly, the impact of hyponatraemia on 30-day mortality
was not significant.
Nationally, the reason for 37.9 % of patients failing to
meet the UK hip fracture BPT target was because of a
perceived need for medical optimisation [17]. At first
glance the rates of delay in our study may seem high. This
was because data collection predated the NICE guidelines
for time to surgery. We realised that the guidelines could
have modified clinical practice owing to the need for
expediting surgery within 36 h. Hence, potential medical
causes for delay that would have otherwise been apparent
prior to the guidelines would potentially be missed fol-
lowing its introduction. Thus, pre-guideline data were used
in an effort to prevent this potential bias.
The median age in both groups of our cohort was above
80 years with a higher proportion of females. This is in
agreement with demographic information published by the
NHFD [18]. With respect to admission source, we found
that a comparatively higher proportion of patients admitted
from their own home with a hip fracture were delayed
beyond 36 h. Conversely, a higher proportion of patients
admitted from a community care institution were seen in
the timely surgery group. It is entirely possible that clinical
practice may have inherently favoured expedited treatment
owing to fears of complications of delayed surgery in
patients who were perceived to be frailer. Such patients are
more likely to present from a community care institution
than their own home [19, 20]. This is also reflected by the
comparatively higher proportion of cardiac related co-
morbidities in the early surgery group.
This study found that the mean international normalised
ratio (INR) and ranges between the two groups were sim-
ilar. This is because patients with comparatively higher
INRs in group 1 had been aggressively treated to correct
the values within the 36-h time frame by using, according
to our institution’s formalised protocol, vitamin k therapy.
This practice is supported by Gleeson et al. who demon-
strated in their cohort of 1080 patients, that an active
management strategy for the reversal of warfarin antico-
agulation facilitated earlier surgery without increasing
complications of thromboembolic events, mortality or
30-day re-admission [21]. Equally, it follows that patients
in group 2 with comparatively normal INRs were delayed
for other reasons.
We found hyponatraemia to be comparatively more
common in the delayed surgery cohort. While we did not
formally explore the underlying reasons for this, anecdotally
we believe that hyponatraemia was perceived to be associ-
ated with peri-operative mortality and morbidity. The asso-
ciation between hyponatraemia and mortality has been
demonstrated previously [22]. However, it has also been
suggested that severe underlying disease is the cause of death
while hyponatraemia is merely another complication of this
underlying disease. Hence, while it shows an association, it
does not necessarily prove causality. Chawla et al. in their
study of just over 45,000 patients found that mortality rates
tended to increase as sodium levels changed from normal to
mild hyponatraemia. Surprisingly, as hyponatraemia
becamemore severe (sodium\120 mmol/l) mortality trends
reversed [23]. Furthermore, over the 12 years of their study,
only three deaths were directly attributable to adverse
hyponatraemia sequelae. Our study also found no difference
in mortality incidence between hypo- and normonatraemic
patients after matching groups for confounders, such as liver
and renal failure, which may have contributed to both mor-
tality and hyponatraemia. This supports the notion that
hyponatraemia may not necessarily be singularly causal to
mortality. Subgroup analysis of those with severe hypona-
traemia (sodium\120 mmol/l) was unfortunately precluded
because there were only three patients that fell into this
category. We cannot therefore draw conclusions as to whe-
ther severe hyponatraemia is a risk factor to mortality and
whether it is reasonable to delay surgery in its presence.
Interestingly, we found that patients with a history of
ischaemic heart disease were significantly less likely to have
their surgery delayed beyond 36 h (23.6 versus 30 %,
p = 0.01). Patients with a history of myocardial infarction
also were significantly less likely to have delayed surgery
(4.1 versus 2.1 %, p = 0.03). These patients may have been
prioritised as these risk factors are non-modifiable and
clinical opinion may have been not to increase their risk
further by also having delayed surgery. Similarly, there is an
increased awareness of the need to avoid unnecessary delays
in order to gain financial compensation for services used in
treating such patients, and to avoid increased costs associ-
ated with longer hospital stays in these patients [24, 25].
The main weakness of this study lies in the fact that we
present data pertaining to only one major trauma unit. One
may argue that patient data from other units may yield
differing results. However, our findings may be more
widely generalisable as our patient population demo-
graphics and mortality rates of 9.0 % (n = 123/1361) at
30 days were comparable to other published studies and
NHFD reports [18, 26, 27]. Although retrospective by
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design, we cross-referenced prospectively collected data
from multiple sources, including a national hip fracture
registry and our own hospital-coding database, ensuring
that the final dataset was reliable. Non-medical risk factors
for delay are not available in the NHFD or medical notes
and hence our regression model is limited by their absence.
We have, however, made a comprehensive assessment of
38 medical and demographic variables. These variables are
readily available on initial presentation and are thus easily
collectable by other units who also wish to make similar
assessments of their services.
This type of study is relevant in the current NHS culture
of target-driven quality health care delivery. Verifying and
investigating the legitimacy of medical causes of surgical
delay is therefore not only pertinent, but has also been
specifically highlighted as a vital area for future research
by the NHFD Scientific Committee [9]. To our knowledge
this study is unique in assessing the risk factors to delay in
achieving the 36-h BPT target in these patients. Nationally,
delays are also due to a lack of theatre time, equipment or
high dependency beds (43 % of the time) [17]. Therefore,
whilst streamlining medical decision-making may help
improve the likelihood of attaining the BPT, availability of
clinical resources plays an important part.
In conclusion, surgical delays can result when one aims
to avoid medical complications associated with hastened
hip fracture surgery. However, delay is not justifiable in the
presence of non-severe and isolated hyponatraemia.
Instead, surgical delay should only be warranted in the
presence of medical conditions which contribute to mor-
tality and are optimisable.
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